OPDIVO QVANTIG

Product NDC
0003-6120
11-digit product format
000036120
Labeler code
0003
Product ID
0003-6120_63db7271-4d46-45d1-99b9-18821495ea77
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
nivolumab and hyaluronidase-nvhy
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
E.R. Squibb & Sons, L.L.C.
Application
BLA761381
Marketing category
BLA
Marketing start
2025-01-02
Substance
HYALURONIDASE (HUMAN RECOMBINANT); NIVOLUMAB
Active strength
2000; 120 U/mL; mg/mL
Pharmacologic classes
Endoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
OPDIVO QVANTIG
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NIVOLUMAB120 mg/mL
HYALURONIDASE (HUMAN RECOMBINANT)2000 U/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
743QUY4VD8Internal UNII lookup
31YO63LBSNInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2700798Internal RxNorm lookup
2700805Internal RxNorm lookup
2728491Internal RxNorm lookup
2728492Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7f8c38fa-42f4-4387-9e8c-7a1c66855d8bAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fba5a780-b52d-4964-b662-1526b044aec4Product name120260127
64196b0b-840e-435b-8afa-0b0e9d9cea99Product name120251024
4b151d8d-9b47-43df-bccb-6abc1c4e7194Product name120250331
d745a796-f789-46a3-afa3-79dead22a863Product name120250331
00bb4496-246c-4f2c-910a-2b2783035958Product name120231025
cc8aeb65-d09e-4803-a7f6-91602fc46900Product name120230103
bd11614e-4776-4a92-aaca-2bcbb5f710edProduct name120210115
0c6eff6a-9a1e-468b-b9ca-6bc864c2e8cbProduct name120200925
6d78c268-2e9d-bd45-9f2d-965fd0e582caProduct name220200323
b914e981-d6dc-4748-bd51-accd6b85b817Product name120190618
4597a7a9-59c8-4eb4-b516-4f26fa3dfe4bProduct name120170804
d9ed9875-2de0-480e-b03d-305aab8310a6Product name220160211
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0003-6120-01OPDIVO QVANTIG1 in 1 CARTONINJECTION, SOLUTION18
0003-6120-01OPDIVO QVANTIG5 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION58

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0003-6120-01ML - Milliliter0003-6120ea2af28d-3522-4351-8f09-fddd13fc516112025-02-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0003-6120OPDIVO QVANTIG (NIVOLUMAB AND HYALURONIDASE-NVHY) INJECTION, SOLUTION [E.R. SQUIBB & SONS, L.L.C.]3Current NDC, 2 package rows20250102_7f8c38fa-42f4-4387-9e8c-7a1c66855d8b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OPDIVO QVANTIGNIVOLUMAB AND HYALURONIDASE-NVHYE.R. Squibb & Sons, L.L.C.7f8c38fa-42f4-4387-9e8c-7a1c66855d8b2026-05-12Warnings, Adverse reactionsExact identifier
application number: BLA761381
ndc (product): 0003-6120

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761381Opdivo Qvantignivolumab and hyaluronidase-nvhy351(a)Rx2026-08-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2728491nivolumab-hyaluronidase-nvhy 300 MG / 5,000 UNT in 2.5 ML InjectionPSN7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2700798nivolumab-hyaluronidase-nvhy 600 MG / 10,000 UNT in 5 ML InjectionPSN7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2728492OPDIVO Qvantig 300 MG / 5,000 UNT in 2.5 ML InjectionPSN7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2700805OPDIVO Qvantig 600 MG / 10,000 UNT in 5 ML InjectionPSN7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
27284922.5 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML Injection [Opdivo Qvantig]SBD7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
27008055 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML Injection [Opdivo Qvantig]SBD7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
27284912.5 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML InjectionSCD7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
27007985 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML InjectionSCD7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2728491nivolumab-hyaluronidase-nvhy 300 MG / 5,000 UNT per 2.5 ML InjectionSY7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2700798nivolumab-hyaluronidase-nvhy 600 MG / 10,000 UNT per 5 ML InjectionSY7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2728492Opdivo Qvantig (nivolumab-hyaluronidase-nvhy 300 MG / 5,000 UNT) per 2.5 ML InjectionSY7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8
2700805Opdivo Qvantig (nivolumab-hyaluronidase-nvhy 600 MG / 10,000 UNT) per 5 ML InjectionSY7f8c38fa-42f4-4387-9e8c-7a1c66855d8b8

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0003-6120-01000036120011 VIAL, SINGLE-DOSE in 1 CARTON (0003-6120-01) / 5 mL in 1 VIAL, SINGLE-DOSE2025-01-02NoNoCurrent